Disposable hypodermic syringes market to exhibit dynamic growth during the forecast period 

The global disposable hypodermic syringes market is witnessing a steady growth, expected to grow at a CAGR of 6.2%. Worldwide, the increasing prevalence of diabetes, multiple sclerosis, and numerous lifestyle diseases will drive the overall market growth. Globally, rising number of surgeries, increased growth of biologics, advancement in hypodermic syringes with fixed dosage, low cost medical devices, and decreased microbial contamination risk along with reduced medication errors are key factors driving the overall growth of the disposable hypodermic syringes market. Additionally, enhanced R&D for disposable syringes, growth in the general and specialized syringes, increasing physician visits and increased product penetration in the hospitals and clinics will further spur revenue growth in the near future. 

Insulin syringes expected to register higher growth by the end of 2027 

Increasing prevalence of Type 1 diabetes and Type 2 diabetes in children and adults will upsurge the demand for insulin delivery. According to the recent edition of the International Diabetes Federation (IDF) Diabetes Atlas 2017, around 424.9 million people were living with diabetes worldwide and estimated to increase by 48% by the end of 2045.  Additionally, a high prevalence of multiple sclerosis and other lifestyle diseases will upsurge the overall demand in the near future. Increased use of single-use dental hypodermic syringes for daily operations will drive revenue growth. Utilization of multishot needle syringes and extraction syringes show steady growth during the forecast period due to its ease of operation, enhanced safety, low cost, and availability. 

Diabetic care centers segment to witness a significant CAGR 

Expansion of diabetes care and services along with increased awareness about overall health management on a global scale will drive the overall growth of the market. Top institutes and organizations in collaboration with healthcare companies are expanding the services in the untapped markets. For e.g. American Association of Diabetes Educators, NCPA Foundation and others. Increased preference for disposable hypodermic syringes in hospitals and clinics as compared to traditional syringes at low cost along with no chances of cross-contamination will show promising growth on a global scale.  Increasing hospital admissions, and expanding outpatient clinics and centers will increase the volume of disposable hypodermic syringes mainly for insulin delivery, vaccination, anesthesia administration and extraction of blood. 

Increased research and development with strong product portfolio in the developed regions 

Major players in the disposable hypodermic syringes market are Becton, Dickinson and Company, Smiths Medical, Terumo Corporation, Albert David Ltd., Nipro Corporation, Medtronic plc, Thermo Fisher Scientific, Gerresheimer AG, B. Braun Medical Inc., Hindustan Syringes & Medical Devices Limited, Changzhou Holinx Industries Co., Ltd., CODAN Medizinische Geräte GmbH & Co KG, ISCON SURGICALS LTD. and others. Innovative product launches with higher patient safety & compatibility, low cost products, partnerships, new technology expansion, and improved R&D on disposable syringes will further spur revenue growth globally.

Historical & Forecast Period

This study report represents analysis of each segment from 2022 to 2032 considering 2023 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2024 to 2032.

The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.

Research Methodology

The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. key data point that enables the estimation of Disposable Hypodermic Syringes market are as follows:

• Research and development budgets of manufacturers and government spending
• Revenues of key companies in the market segment
• Number of end users and consumption volume, price and value.
• Geographical revenues generate by countries considered in the report
• Micro and macro environment factors that are currently influencing the Disposable Hypodermic Syringes market and their expected impact during the forecast period.

Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top down and bottom-up approach for validation of market estimation assures logical, methodical and mathematical consistency of the quantitative data.

Key questions answered in this report

• What are the key micro and macro environmental factors that are impacting the growth of Disposable Hypodermic Syringes market?
• What are the key investment pockets with respect to product segments and geographies currently and during the forecast period?
• Estimated forecast and market projections up to 2032.
• Which segment accounts for the fastest CAGR during the forecast period?
• Which market segment holds a larger market share and why?
• Are low and middle-income economies investing in the Disposable Hypodermic Syringes market?
• Which is the largest regional market for Disposable Hypodermic Syringes market?
• What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?
• Which are the key trends driving Disposable Hypodermic Syringes market growth?
• Who are the key competitors and what are their key strategies to enhance their market presence in the Disposable Hypodermic Syringes market worldwide?